A recent study from the University of Missouri has brought attention to the potential risks associated with Nicotinamide Riboside (NR), a form of vitamin B3 commonly used in dietary supplements.
This research particularly focuses on the implications of NR in relation to cancer development and spread.
The Connection Between NR and Cancer
The study revealed that high levels of NR could potentially increase the risk of developing triple-negative breast cancer. More alarmingly, it also indicated that NR might facilitate the spread of this cancer to the brain.
This finding is particularly concerning due to the current lack of effective treatments for brain metastases.
NR’s Impact on Cancer Cells
NR is known for its ability to boost cellular energy, which is generally considered beneficial for health. However, cancer cells, which are characterized by their high metabolism, could misuse this surplus energy.
This misuse could lead to the accelerated growth and spread of cancer cells. The research team’s approach involved examining the levels of NR in cancer cells, T cells, and healthy tissues to understand how NR supplementation might influence cancer development.
The Need for Caution with Supplements
This study highlights the importance of thorough investigation into the side effects of supplements like NR, especially for people with various health conditions.
It serves as a cautionary tale about the potential risks of unregulated supplement use, particularly in individuals who may be at risk of cancer.
Future Research and Personalized Medicine
Looking ahead, the research team aims to explore ways to potentially inhibit the effects of NR on cancer cells. Their goal is to make cancer therapies, such as chemotherapy, more effective.
They advocate for a personalized approach to cancer treatment, recognizing that cancers vary significantly among individuals. This variability includes differences in metabolic profiles, which can change in response to treatments like chemotherapy.
Research Contributions and Publication
Conducted by Elena Goun and her team, this study, published in the journal Biosensors and Bioelectronics, provides crucial insights into the complex dynamics between dietary supplements and cancer development.
It underscores the importance of personalized medicine in cancer treatment and the need for careful consideration of supplement use in cancer risk populations.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more information about cancer, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Copyright © 2023 Knowridge Science Report. All rights reserved.
